Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ventilator-associated Bacterial Pneumonia (VABP)”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Large-scale testing (Phase 3)UnknownNCT01865266
What this trial is testing

The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia

Who this might be right for
Ventilator-associated Bacterial PneumoniaMechanical Ventilation Complication
Shanghai Minhang Central Hospital 60
Large-scale testing (Phase 3)Looking for participantsNCT07327619
What this trial is testing

Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP

Who this might be right for
Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia
Qilu Pharmaceutical Co., Ltd. 420
Large-scale testing (Phase 3)Study completedNCT02493764
What this trial is testing

Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)

Who this might be right for
Bacterial Pneumonia
Merck Sharp & Dohme LLC 537
Testing effectiveness (Phase 2)Looking for participantsNCT06841731
What this trial is testing

A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

Who this might be right for
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)
Jiangsu HengRui Medicine Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT04215991
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants

Who this might be right for
Gram-negative Bacterial InfectionsHospital Acquired Bacterial Pneumonia (HABP)Complicated Urinary Tract Infection (cUTI)+1 more
Shionogi 91
Post-approval studies (Phase 4)Looking for participantsNCT07004049
What this trial is testing

Optimising TREATment for Severe Gram-Negative Bacterial Infections

Who this might be right for
Bloodstream InfectionVentilator Associated Bacterial PneumoniaHospital Acquired Bacterial Pneumonia+2 more
National University of Singapore 600
Testing effectiveness (Phase 2)Study completedNCT05685615
What this trial is testing

PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB

Who this might be right for
Ventilator Associated Pneumonia
BioVersys AG 39
Testing effectiveness (Phase 2)Study completedNCT06086626
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Who this might be right for
Gram-Negative Bacterial Infections
Shionogi 30
Large-scale testing (Phase 3)WithdrawnNCT06168734
What this trial is testing

Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP

Who this might be right for
Ventilator-associated PneumoniaHospital-acquired Pneumonia
Venatorx Pharmaceuticals, Inc.
Not applicableStudy completedNCT02288234
What this trial is testing

Telavancin Observational Use Registry (TOUR)

Who this might be right for
Hospital Acquired Bacterial PneumoniaComplicated Skin and Skin Structure InfectionsVentilator Associated Bacterial Pneumonia+1 more
Cumberland Pharmaceuticals 1,063
Not applicableStudy completedNCT02689531
What this trial is testing

CTTI Risk Factors for HABP/VABP Study

Who this might be right for
Pneumonia, Ventilator-AssociatedPneumonia, BacterialPneumonia, Hospital-Acquired
Duke University 7,530
Large-scale testing (Phase 3)Study completedNCT03583333
What this trial is testing

Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)

Who this might be right for
Hospital-Acquired Bacterial PneumoniaVentilator-Associated Bacterial Pneumonia
Merck Sharp & Dohme LLC 274
Large-scale testing (Phase 3)Ended earlyNCT03409679
What this trial is testing

Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa

Who this might be right for
Pneumonia
Polyphor Ltd. 41
Large-scale testing (Phase 3)Study completedNCT03032380
What this trial is testing

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

Who this might be right for
Healthcare-associated Pneumonia (HCAP)Hospital Acquired Pneumonia (HAP)Ventilator Associated Pneumonia (VAP)
Shionogi 300
Large-scale testing (Phase 3)Study completedNCT02168946
What this trial is testing

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Who this might be right for
Urinary Tract Infection ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+3 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 77
Early research (Phase 1)Looking for participantsNCT06801223
What this trial is testing

Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Who this might be right for
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Innoviva Specialty Therapeutics 48
Not applicableStudy completedNCT02728518
What this trial is testing

Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia

Who this might be right for
Pneumonia
National Heart Institute, Egypt 133
Large-scale testing (Phase 3)Study completedNCT05204563
What this trial is testing

Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)

Who this might be right for
Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
Evopoint Biosciences Inc. 450
Testing effectiveness (Phase 2)Ended earlyNCT01570192
What this trial is testing

Clinical Trials to Reduce the Risk of Antimicrobial Resistance

Who this might be right for
Bacterial Pneumonia
University of Florida 43
Large-scale testing (Phase 3)Study completedNCT05905055
What this trial is testing

P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales

Who this might be right for
Complicated Urinary Tract InfectionAcute PyelonephritisHospital-acquired Bacterial Pneumonia+2 more
Meiji Seika Pharma Co., Ltd. 126
Load More Results